Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479515 · ClinicalTrials.gov registry record
Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 80
- Enrollment target
NCT03479515: Completed study, sponsored by University of Minnesota.
NCT03479515 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479515 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The overall objective of the proposal is to evaluate the ability of ultrasound to predict the body composition of toddlers in the outpatient clinical setting and to evaluate the relationship between body composition and neurodevelopment.
Primary Outcome
Tissue thickness (adipose and muscle) will be measured in cm using the ultrasound probe.
Interventions
- DEVICE Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2023-06-06 |
What the finished NCT03479515 record still lists
NCT03479515 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound is the first listed.
NCT03479515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03479515 about?
NCT03479515 is a clinical study titled "Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes". The overall objective of the proposal is to evaluate the ability of ultrasound to predict the body composition of toddlers in the outpatient clinical setting and to evaluate the relationship between body composition and neurodevelopment.
What is the current status of trial NCT03479515?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2018-07-20. Estimated completion is 2023-06-06.
What interventions are being tested in trial NCT03479515?
The interventions under investigation include: Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03479515?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI